Sulfasalazine in dermatology: A lesser explored drug with broad therapeutic potential
Open Access
- 1 June 2020
- journal article
- review article
- Published by Wolters Kluwer Health in International Journal of Women's Dermatology
- Vol. 6 (3) , 191-198
Abstract
Sulfasalazine is an aminosalicylate primarily used in the treatment of rheumatoid arthritis and ulcerative colitis. Its immunomodulatory, anti-inflammatory, and antiproliferative properties make it a potential therapeutic option for various dermatological disorders. Owing to its wide range of effects, it is often used off-label in dermatological diseases, such as alopecia areata, psoriasis and psoriatic arthritis, lichen planus, and pemphigus. However, the level of evidence supporting its efficacy and safety in dermatology is limited. More research is needed to uncover the full potential of sulfasalazine in dermatology. The present article is a detailed review of the pharmacology, modes of action, side effects, and contraindications of sulfasalazine, along with an up-to-date review of the evidence underlying its use in various dermatological conditions.Keywords
This publication has 70 references indexed in Scilit:
- Sulfasalazine induced lichen planus in a patient of rheumatoid arthritisIndian Journal of Dermatology, Venereology and Leprology, 2013
- Pyoderma gangrenosum: An updateIndian Dermatology Online Journal, 2012
- New Evidence-Based Treatment Approach in Behçet's DiseasePathology Research International, 2011
- Sequential Combination Therapy Leading to Sustained Remission in a Patient with SAPHO SyndromeThe Open Rheumatology Journal, 2009
- SulfasalazineDrugs, 2005
- SulfasalazineDrugs, 1995
- Clinical Pharmacokinetics of Slow-Acting Antirheumatic DrugsClinical Pharmacokinetics, 1993
- Sulfasalazine in atrophie blancheJournal of the American Academy of Dermatology, 1993
- The Effect of Age and Acetylator Phenotype on the Pharmacokinetics of Sulfasalazine in Patients with Rheumatoid ArthritisClinical Pharmacokinetics, 1992
- Sulfasalazine: A potential psoriasis therapy?Journal of the American Academy of Dermatology, 1989